Francis Bouchet

For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time

Avigaëlle Sher, Franck Lacœuille, Pacôme Fosse et al. · EJNMMI Research · 2016 · 116 citations · Full text

Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model

Claire Vanpouille‐Box, Franck Lacœuille, J. Roux et al. · PLoS ONE · 2011 · 39 citations · Full text

Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model

Annabelle Cikankowitz, Anne Clavreul, Clément Tétaud et al. · Journal of Neuro-Oncology · 2016 · 24 citations

Nanomedicine, Neuro-oncology, 188Re-lipid Nanocapsules +10

Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)

Héléna Pereira, Mohamed Bouattour, Marco Dioguardi Burgio et al. · European Journal of Cancer · 2021 · 18 citations · Full text

Sarah Trial, Quality Of Life, Hepatology +11

Calibration Test of PET Scanners in a Multi-Centre Clinical Trial on Breast Cancer Therapy Monitoring Using 18F-FLT

Francis Bouchet, Lilli Geworski, Bernd O. Knoop et al. · PLoS ONE · 2013 · 16 citations · Full text